| Home | E-Submission | Sitemap | Contact Us |  
top_img
Cancer Research and Treatment > Accepted Articles
doi: https://doi.org/10.4143/crt.2023.1043    [Accepted]
Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP
Miso Kim1 , Hyo Sup Shim2, Sheehyun Kim3, In Hee Lee4, Jihun Kim5, Shinkyo Yoon6, Hyung-Don Kim6, Inkeun Park6, Jae Ho Jeong6, Changhoon Yoo6, Jaekyung Cheon6, In-Ho Kim7, Jieun Lee7, Sook Hee Hong7, Sehhoon Park8, Hyun Ae Jung8, Jin Won Kim9, Han Jo Kim10, Yongjun Cha11, Sun Min Lim12, Han Sang Kim12, Choong-kun Lee12, Jee Hung Kim13, Sang Hoon Chun14, Jina Yun15, So Yeon Park16, Hye Seung Lee17, Yong Mee Cho5, Soo Jeong Nam5, Kiyong Na18, Sun Och Yoon2, Ahwon Lee19, Kee-Taek Jang20, Hongseok Yun3, Sungyoung Lee3, Jee Hyun Kim9 , Wan-Seop Kim21
1Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
2Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
3Department of Genomic Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
4Department of Oncology and Hematology, Kyungpook National Chilgok University Hospital, Kyungpook National University School of Medicine, Daegu, Korea
5Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
6Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
7Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
8Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
9Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
10Division of Oncology and Hematology, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea
11Division of Medical Oncology, Center for Colorectal Cancer, National Cancer Center, Goyang, Korea
12Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
13Division of Medical Oncology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
14Division of Medical Oncology, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
15Division of Hematology/Oncology, Department of Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
16Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
17Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
18Department of Pathology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea
19Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea
20Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
21Department of Pathology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea

This article has been published jointly, with consent, in both Cancer Research and Treatment and Journal of Pathology and Translational Medicine.
Correspondence  Jee Hyun Kim ,Tel: 82-31-787-7022, Fax: 82-31-787-7098, Email: jhkimmd@snu.ac.kr
Wan-Seop Kim ,Tel: 82-2-2030-5642, Fax: 82-2-2030-5629, Email: wskim@kuh.ac.kr
Received: September 13, 2023;  Accepted: November 17, 2023.  Published online: November 29, 2023.
ABSTRACT
In recent years, next-generation sequencing (NGS)-based genetic testing has become crucial in cancer care. While its primary objective is to identify actionable genetic alterations to guide treatment decisions, its scope has broadened to encompass aiding in pathological diagnosis and exploring resistance mechanisms. With the ongoing expansion in NGS application and reliance, a compelling necessity arises for expert consensus on its application in solid cancers. To address this demand, the forthcoming recommendations not only provide pragmatic guidance for the clinical use of NGS but also systematically classify actionable genes based on specific cancer types. Additionally, these recommendations will incorporate expert perspectives on crucial biomarkers, ensuring informed decisions regarding circulating tumor DNA panel testing.
Key words: Next-generation sequencing, Solid cancer, Precision medicine, Korea
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI